MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX:CXS) (NASDAQ:CXSP) today announced the appointment of Adam R. Craig MD, PhD, MBA as Senior Vice President and Chief Medical Officer. In this position, Dr. Craig will leverage more than 15 years of clinical, oncology and drug development experience to direct ChemGenex’s global clinical development strategies and to design and implement clinical trials to evaluate the company's pipeline of novel cancer therapeutic agents. Dr. Craig also will be responsible for building and leading ChemGenex’s clinical development and translational medicine team.
